Indication
Indicated for the reduction of intraocular pressure (IOP) in adults with open angle glaucoma (OAG) or ocular hypertension (OHT) who are unsuitable for topical IOP-lowering medications.
Loading your page…
Loading your page…
Glaucoma, Open-Angle;Ocular Hypertension
Marketing Authorisation Holder: AbbVie Deutschland GmbH & Co. KG
INN: bimatoprost
AI Drug & Interaction Analysis
Free account required
Ask Osler about Durysta: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.